位置:首页 > 蛋白库 > EDAD_HUMAN
EDAD_HUMAN
ID   EDAD_HUMAN              Reviewed;         215 AA.
AC   Q8WWZ3; A2VCK5; A8K7B5; B1AL54; B9ZVW5; Q5VYJ7;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 3.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Ectodysplasin-A receptor-associated adapter protein;
DE   AltName: Full=EDAR-associated death domain protein;
DE   AltName: Full=Protein crinkled homolog;
GN   Name=EDARADD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND VARIANT ECTD11B LYS-152.
RX   PubMed=11780064; DOI=10.1038/414913a;
RA   Headon D.J., Emmal S.A., Ferguson B.M., Tucker A.S., Justice M.J.,
RA   Sharpe P.T., Zonana J., Overbeek P.A.;
RT   "Gene defect in ectodermal dysplasia implicates a DEATH domain adapter in
RT   development.";
RL   Nature 414:913-916(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND FUNCTION.
RC   TISSUE=Skin;
RX   PubMed=11882293; DOI=10.1016/s0960-9822(02)00687-5;
RA   Yan M., Zhang Z., Brady J.R., Schilbach S., Fairbrother W.J., Dixit V.M.;
RT   "Identification of a novel DEATH domain-containing adaptor molecule for
RT   ectodysplasin-A receptor that is mutated in crinkled mice.";
RL   Curr. Biol. 12:409-413(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), NUCLEOTIDE SEQUENCE [GENOMIC DNA],
RP   AND VARIANT ILE-9.
RA   Emmal S.A., Ferguson B.M., Zonana J.;
RT   "A novel death domain adapter required for ectodermal development.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B), AND VARIANT
RP   ILE-9.
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A), AND VARIANT ILE-9.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   VARIANT ECTD11A ARG-122, CHARACTERIZATION OF VARIANT ECTD11A ARG-122, AND
RP   CHARACTERIZATION OF VARIANT ECTD11B LYS-152.
RX   PubMed=17354266; DOI=10.1002/humu.20500;
RA   Bal E., Baala L., Cluzeau C., El Kerch F., Ouldim K., Hadj-Rabia S.,
RA   Bodemer C., Munnich A., Courtois G., Sefiani A., Smahi A.;
RT   "Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD
RT   locus.";
RL   Hum. Mutat. 28:703-709(2007).
RN   [9]
RP   VARIANT PHE-103.
RX   PubMed=18231121; DOI=10.1038/sj.ejhg.5202012;
RA   van der Hout A.H., Oudesluijs G.G., Venema A., Verheij J.B.G.M.,
RA   Mol B.G.J., Rump P., Brunner H.G., Vos Y.J., van Essen A.J.;
RT   "Mutation screening of the ectodysplasin-A receptor gene EDAR in
RT   hypohidrotic ectodermal dysplasia.";
RL   Eur. J. Hum. Genet. 16:673-679(2008).
RN   [10]
RP   VARIANT ECTD11B 135-THR-VAL-136 DEL, AND CHARACTERIZATION OF VARIANT
RP   ECTD11B 135-THR-VAL-136 DEL.
RX   PubMed=20222921; DOI=10.1111/j.1365-2133.2010.09670.x;
RA   Chassaing N., Cluzeau C., Bal E., Guigue P., Vincent M.C., Viot G.,
RA   Ginisty D., Munnich A., Smahi A., Calvas P.;
RT   "Mutations in EDARADD account for a small proportion of hypohidrotic
RT   ectodermal dysplasia cases.";
RL   Br. J. Dermatol. 162:1044-1048(2010).
RN   [11]
RP   VARIANT ECTD11A TYR-114.
RX   PubMed=20979233; DOI=10.1002/humu.21384;
RA   Cluzeau C., Hadj-Rabia S., Jambou M., Mansour S., Guigue P., Masmoudi S.,
RA   Bal E., Chassaing N., Vincent M.C., Viot G., Clauss F., Maniere M.C.,
RA   Toupenay S., Le Merrer M., Lyonnet S., Cormier-Daire V., Amiel J.,
RA   Faivre L., de Prost Y., Munnich A., Bonnefont J.P., Bodemer C., Smahi A.;
RT   "Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of
RT   hypohidrotic/anhidrotic ectodermal dysplasia cases.";
RL   Hum. Mutat. 32:70-72(2011).
CC   -!- FUNCTION: Adapter protein that interacts with EDAR DEATH domain and
CC       couples the receptor to EDA signaling pathway during morphogenesis of
CC       ectodermal organs. Mediates the activation of NF-kappa-B.
CC       {ECO:0000269|PubMed:11882293}.
CC   -!- SUBUNIT: Self-associates and binds EDAR, TRAF1, TRAF2 and TRAF3.
CC   -!- INTERACTION:
CC       Q8WWZ3; Q96HA8: NTAQ1; NbExp=4; IntAct=EBI-2949647, EBI-741158;
CC       Q8WWZ3; Q6ZNA4: RNF111; NbExp=3; IntAct=EBI-2949647, EBI-2129175;
CC       Q8WWZ3; O00560: SDCBP; NbExp=3; IntAct=EBI-2949647, EBI-727004;
CC       Q8WWZ3; Q149N8: SHPRH; NbExp=3; IntAct=EBI-2949647, EBI-714105;
CC       Q8WWZ3; P63165: SUMO1; NbExp=5; IntAct=EBI-2949647, EBI-80140;
CC       Q8WWZ3; G2XKQ0: SUMO1P1; NbExp=5; IntAct=EBI-2949647, EBI-10175576;
CC       Q8WWZ3; Q12933: TRAF2; NbExp=5; IntAct=EBI-2949647, EBI-355744;
CC       Q8WWZ3; Q9Y4K3: TRAF6; NbExp=5; IntAct=EBI-2949647, EBI-359276;
CC       Q8WWZ3; P63279: UBE2I; NbExp=3; IntAct=EBI-2949647, EBI-80168;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=Q8WWZ3-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q8WWZ3-2; Sequence=VSP_003861;
CC   -!- TISSUE SPECIFICITY: Detected in adult pancreas, placenta and fetal
CC       skin, and at lower levels in lung, thymus, prostate and testis.
CC   -!- DISEASE: Ectodermal dysplasia 11A, hypohidrotic/hair/nail type,
CC       autosomal dominant (ECTD11A) [MIM:614940]: A form of ectodermal
CC       dysplasia, a heterogeneous group of disorders due to abnormal
CC       development of two or more ectodermal structures. It is an autosomal
CC       dominant condition characterized by hypotrichosis, abnormal or missing
CC       teeth, and hypohidrosis due to the absence of sweat glands.
CC       {ECO:0000269|PubMed:17354266, ECO:0000269|PubMed:20979233}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type,
CC       autosomal recessive (ECTD11B) [MIM:614941]: A disorder due to abnormal
CC       development of two or more ectodermal structures, and characterized by
CC       sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth
CC       and the inability to sweat due to the absence of sweat glands.
CC       {ECO:0000269|PubMed:11780064, ECO:0000269|PubMed:17354266,
CC       ECO:0000269|PubMed:20222921}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY028914; AAK40288.1; -; mRNA.
DR   EMBL; AY071862; AAL60590.1; -; mRNA.
DR   EMBL; AY028912; AAK40285.1; -; Genomic_DNA.
DR   EMBL; AY028906; AAK40285.1; JOINED; Genomic_DNA.
DR   EMBL; AY028908; AAK40285.1; JOINED; Genomic_DNA.
DR   EMBL; AY028909; AAK40285.1; JOINED; Genomic_DNA.
DR   EMBL; AY028910; AAK40285.1; JOINED; Genomic_DNA.
DR   EMBL; AY028911; AAK40285.1; JOINED; Genomic_DNA.
DR   EMBL; AY028912; AAK40286.1; -; Genomic_DNA.
DR   EMBL; AY028907; AAK40286.1; JOINED; Genomic_DNA.
DR   EMBL; AY028908; AAK40286.1; JOINED; Genomic_DNA.
DR   EMBL; AY028909; AAK40286.1; JOINED; Genomic_DNA.
DR   EMBL; AY028910; AAK40286.1; JOINED; Genomic_DNA.
DR   EMBL; AY028911; AAK40286.1; JOINED; Genomic_DNA.
DR   EMBL; AY028913; AAK40287.1; -; mRNA.
DR   EMBL; AK290862; BAF83551.1; -; mRNA.
DR   EMBL; AK291930; BAF84619.1; -; mRNA.
DR   EMBL; AK314634; BAG37197.1; -; mRNA.
DR   EMBL; AL354693; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136105; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW70052.1; -; Genomic_DNA.
DR   EMBL; BC128082; AAI28083.1; -; mRNA.
DR   CCDS; CCDS1610.1; -. [Q8WWZ3-1]
DR   CCDS; CCDS31065.1; -. [Q8WWZ3-2]
DR   RefSeq; NP_542776.1; NM_080738.3. [Q8WWZ3-2]
DR   RefSeq; NP_665860.2; NM_145861.2. [Q8WWZ3-1]
DR   AlphaFoldDB; Q8WWZ3; -.
DR   SMR; Q8WWZ3; -.
DR   BioGRID; 126096; 14.
DR   IntAct; Q8WWZ3; 12.
DR   STRING; 9606.ENSP00000335076; -.
DR   iPTMnet; Q8WWZ3; -.
DR   PhosphoSitePlus; Q8WWZ3; -.
DR   BioMuta; EDARADD; -.
DR   DMDM; 212276512; -.
DR   EPD; Q8WWZ3; -.
DR   jPOST; Q8WWZ3; -.
DR   MassIVE; Q8WWZ3; -.
DR   MaxQB; Q8WWZ3; -.
DR   PaxDb; Q8WWZ3; -.
DR   PeptideAtlas; Q8WWZ3; -.
DR   PRIDE; Q8WWZ3; -.
DR   ProteomicsDB; 74963; -. [Q8WWZ3-1]
DR   ProteomicsDB; 74964; -. [Q8WWZ3-2]
DR   Antibodypedia; 20814; 37 antibodies from 14 providers.
DR   DNASU; 128178; -.
DR   Ensembl; ENST00000334232.9; ENSP00000335076.4; ENSG00000186197.15. [Q8WWZ3-1]
DR   Ensembl; ENST00000359362.6; ENSP00000352320.4; ENSG00000186197.15. [Q8WWZ3-2]
DR   GeneID; 128178; -.
DR   KEGG; hsa:128178; -.
DR   MANE-Select; ENST00000334232.9; ENSP00000335076.4; NM_145861.4; NP_665860.2.
DR   UCSC; uc001hxu.2; human. [Q8WWZ3-1]
DR   CTD; 128178; -.
DR   DisGeNET; 128178; -.
DR   GeneCards; EDARADD; -.
DR   GeneReviews; EDARADD; -.
DR   HGNC; HGNC:14341; EDARADD.
DR   HPA; ENSG00000186197; Tissue enhanced (urinary).
DR   MalaCards; EDARADD; -.
DR   MIM; 606603; gene.
DR   MIM; 614940; phenotype.
DR   MIM; 614941; phenotype.
DR   neXtProt; NX_Q8WWZ3; -.
DR   OpenTargets; ENSG00000186197; -.
DR   Orphanet; 1810; Autosomal dominant hypohidrotic ectodermal dysplasia.
DR   Orphanet; 248; Autosomal recessive hypohidrotic ectodermal dysplasia.
DR   Orphanet; 99798; Oligodontia.
DR   PharmGKB; PA27603; -.
DR   VEuPathDB; HostDB:ENSG00000186197; -.
DR   eggNOG; KOG4602; Eukaryota.
DR   GeneTree; ENSGT00390000001136; -.
DR   HOGENOM; CLU_085398_0_0_1; -.
DR   InParanoid; Q8WWZ3; -.
DR   OMA; DKDTQNH; -.
DR   OrthoDB; 1140603at2759; -.
DR   PhylomeDB; Q8WWZ3; -.
DR   TreeFam; TF335658; -.
DR   PathwayCommons; Q8WWZ3; -.
DR   Reactome; R-HSA-5669034; TNFs bind their physiological receptors.
DR   SignaLink; Q8WWZ3; -.
DR   BioGRID-ORCS; 128178; 11 hits in 1073 CRISPR screens.
DR   ChiTaRS; EDARADD; human.
DR   GeneWiki; EDARADD; -.
DR   GenomeRNAi; 128178; -.
DR   Pharos; Q8WWZ3; Tbio.
DR   PRO; PR:Q8WWZ3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8WWZ3; protein.
DR   Bgee; ENSG00000186197; Expressed in islet of Langerhans and 93 other tissues.
DR   ExpressionAtlas; Q8WWZ3; baseline and differential.
DR   Genevisible; Q8WWZ3; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.533.10; -; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR039200; EDARADD.
DR   PANTHER; PTHR28469; PTHR28469; 1.
DR   Pfam; PF00531; Death; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Developmental protein; Differentiation;
KW   Disease variant; Ectodermal dysplasia; Reference proteome.
FT   CHAIN           1..215
FT                   /note="Ectodysplasin-A receptor-associated adapter protein"
FT                   /id="PRO_0000086928"
FT   DOMAIN          123..202
FT                   /note="Death"
FT   REGION          1..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          62..86
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        14..29
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        62..79
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..20
FT                   /note="MGLRTTKQMGRGTKAPGHQE -> MASPDDPLRA (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:11780064,
FT                   ECO:0000303|PubMed:11882293, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_003861"
FT   VARIANT         9
FT                   /note="M -> I (in dbSNP:rs966365)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3"
FT                   /id="VAR_050963"
FT   VARIANT         103
FT                   /note="S -> F (in dbSNP:rs114632254)"
FT                   /evidence="ECO:0000269|PubMed:18231121"
FT                   /id="VAR_054509"
FT   VARIANT         114
FT                   /note="D -> Y (in ECTD11A)"
FT                   /evidence="ECO:0000269|PubMed:20979233"
FT                   /id="VAR_064835"
FT   VARIANT         122
FT                   /note="L -> R (in ECTD11A; severely impairs NF-kappa-B
FT                   activation and acted in a dominant-negative manner;
FT                   dbSNP:rs121908116)"
FT                   /evidence="ECO:0000269|PubMed:17354266"
FT                   /id="VAR_054510"
FT   VARIANT         135..136
FT                   /note="Missing (in ECTD11B; impairs the interaction with
FT                   EDAR and severely inhibits NF-kappa-B activity)"
FT                   /evidence="ECO:0000269|PubMed:20222921"
FT                   /id="VAR_064836"
FT   VARIANT         152
FT                   /note="E -> K (in ECTD11B; may reduce binding to EDAR;
FT                   impairs NF-kappa-B activation by about 50%;
FT                   dbSNP:rs74315309)"
FT                   /evidence="ECO:0000269|PubMed:11780064,
FT                   ECO:0000269|PubMed:17354266"
FT                   /id="VAR_013482"
SQ   SEQUENCE   215 AA;  24802 MW;  25C198E3CA1F68F2 CRC64;
     MGLRTTKQMG RGTKAPGHQE DHMVKEPVED TDPSTLSFNM SDKYPIQDTE LPKAEECDTI
     TLNCPRNSDM KNQGEENGFP DSTGDPLPEI SKDNSCKENC TCSSCLLRAP TISDLLNDQD
     LLDVIRIKLD PCHPTVKNWR NFASKWGMSY DELCFLEQRP QSPTLEFLLR NSQRTVGQLM
     ELCRLYHRAD VEKVLRRWVD EEWPKRERGD PSRHF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024